UK markets closed

Artelo Biosciences, Inc. (ARTL)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
1.3261+0.0361 (+2.80%)
At close: 04:00PM EDT
1.3000 -0.03 (-1.97%)
After hours: 04:19PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/08/2021
31/08/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
3,784
5,696
4,324
2,839
1,919
Selling general and administrative
5,633
4,234
5,963
4,602
2,767
Total operating expenses
9,417
9,930
10,287
7,441
4,686
Operating income or loss
-9,417
-9,930
-10,287
-7,441
-4,686
Interest expense
0
0
5
0
-
Total other income/expenses net
641
641
207
2
30
Income before tax
-9,407
-9,289
-10,083
-7,437
-4,655
Income tax expense
0
0
0
0
0
Income from continuing operations
-9,407
-9,289
-10,083
-7,437
-4,655
Net income
-9,407
-9,289
-10,083
-7,437
-4,655
Net income available to common shareholders
-9,407
-9,289
-10,083
-7,437
-4,655
Basic EPS
-3.33
-
-3.56
-5.97
-18.90
Diluted EPS
-3.33
-
-3.56
-5.97
-18.90
Basic average shares
2,874
-
2,833
1,245
247.176
Diluted average shares
2,874
-
2,833
1,245
247.176